All Things Chromatography

We Work For Health honors Sen. Carper

U.S. Senator Tom Carper of Delaware was presented with this year’s Medical Innovation Champion award by the Dayton and EppesDelaware Chapter of We Work for Health (WWFH) at Junior Achievement of Delaware (JA) in Wilmington on August 27. The award was furnished in conjunction with a WWFH roundtable discussion on the future of medical innovation in Delaware.
Senator Carper’s work has been of tremendous importance to the robust medical innovation industry in Delaware, and the workforce and economic support it provides. He has been a strong supporter of the innovators, helping ensure they are able to recoup their investments with the protection of data exclusivity rights in health care reform. He is an advocate and supporter of the Delaware Health Information Network (DHIN) and Delaware becoming the first state to roll out electronic health records statewide.

“Senator Carper has gone to bat for innovators here in Delaware and around the country,” said Frank Howard, WWFH Campaign Manager. “His leadership in health care reform was critical in keeping important research alive.”
Medical innovation leaders in Delaware held a roundtable discussion following the award covering several issues of importance to the continued support of medical innovation in Delaware. Topics covered included narrowing gaps in translation research so more lab discoveries make it to market; navigating current limitations on private investment; reforming the Food and Drug Administration’s regulatory review process; and stimulating the cultivation of new innovators through Science, Technology, Engineering, and Mathematics (STEM) education and other programs.
“Today’s gathering allowed for important discussions on what steps we need to be taking to support future innovators,” said JA President and WWFH Delaware Chapter Co-Chair Rob Eppes. “Here at Junior Achievement, we are doing our part to prepare today’s students to be tomorrow’s leaders in medical innovation and research.”

Attendees were invited on a tour of JA’s Innovation Hub by Eppes. The Hub is a STEM career exploration zone within the JA World experiential learning center. Through virtual expeditions, students are able to explore local STEM career opportunities and the associated educational requirements. Preparations are underway for the Hub to host 2,700 students for the JA Innovation Hub Career and College Readiness Experience in late September.
Roundtable participants included representatives from: AIDS Delaware; Analtech, Inc.; Christiana Care Health System; Delaware AFL-CIO; Delaware Bioscience Association; Delaware Biotechnology Institute; Delaware Economic Development Office; Delaware Healthcare Commission; Delaware HIV Consortium; Delaware State University; Junior Achievement of Delaware; and Mid-Atlantic Association of Community Health Centers.
We Work for Health is a grassroots initiative that unites health consumers, biopharmaceutical company employees and retirees, vendors, suppliers and other business, academic and community partners to demonstrate how these diverse groups work together to improve America’s health care system and strengthen our economy.

Topics: Pharmaceutical Industry, BIO, Pharma, Pharma Industry

Social Media featured in Life Science Leader

As the Bio and Pharma industries continue to explore the use of social media (blogs, facebook, twitter, etc.) we're seeing more articles being written about who is using it and how they are doing so.

Life Science Leader's December issue Cover Story is The Differing Views Of Using Social Media In PharmLife Science Leadera by Cliff Mintz, here's a couple of excerpts:

Regardless of the social media application or platform technology that is used, “It’s all about communication and engaging others in an ongoing conversation or dialogue,” says Ken Grant, a social media enthusiast and director of sales and marketing of Analtech


The industry’s reluctance to engage in social media puzzles John Mack, a veteran pharmaceutical consultant, blogger, and social media enthusiast who publishes the influential Pharma Marketing News newsletter and the Pharma Marketing blog. “Social media has drastically changed the way people communicate over the Internet. It is a two-way dialog that makes discussions and the exchange of information available to masses of people who previously may not have had access,” he said. The industry needs to better understand its benefits and get into the game, Mack added. Analtech’s Grant asserts that life sciences companies have to come to terms with the fact that conversations about them are already taking place online whether or not they are aware of them. “Companies should understand that they must monitor social media channels to better understand what their customers and stakeholders are saying and what they need or want,” he said.

One pharmaceutical company that understands this is Wilmington, DE-based AstraZeneca, which several years ago opened a couple of branded video channels on YouTube and more recently joined Twitter. Earl Whipple, AstraZenecaUS senior director of business and digital media communications, said, “Before we launched our @AstraZenecaUS Twitter account, our company was already the subject of numerous tweets, so it only made sense to join the conversation. We not only want to be part of conversations about AstraZeneca and important health topics, but we also want to listen to what people are saying about the company and the industry.”

Click Here to read the complete article

Topics: Social Media, Pharma Industry, Life Science Leader